FibroGen (FGEN) Reports Q1 Loss of $0.53/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. MRVL
7. ABBV
8. CL
9. CHKP
10. ON

Go back to FibroGen (FGEN) Reports Q1 Loss of $0.53/Share

FibroGen Reports First Quarter 2019 Financial Results

May 9, 2019 4:45 PM EDT

Positive topline results from pooled safety analyses of roxadustat Phase 3 global programCompleted one year of treatment in Phase 2 trial evaluating pamrevlumab in treatment of non-ambulatory DMD patients

Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time

SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the first quarter of 2019 and provided an update on the companys recent developments.

The first quarter of 2019 saw critical execution across multiple programs.... More